Search hospitals > Pennsylvania > Pittsburgh
UPMC-Presbyterian Hospital
Claim this profilePittsburgh, Pennsylvania 15213
Global Leader in Breast Cancer
Global Leader in Parotid Gland Cancer
Conducts research for Lung Cancer
Conducts research for Heart Failure
Conducts research for Stroke
306 reported clinical trials
33 medical researchers
Summary
UPMC-Presbyterian Hospital is a medical facility located in Pittsburgh, Pennsylvania. This center is recognized for care of Breast Cancer, Parotid Gland Cancer, Lung Cancer, Heart Failure, Stroke and other specialties. UPMC-Presbyterian Hospital is involved with conducting 306 clinical trials across 532 conditions. There are 33 research doctors associated with this hospital, such as Liza C. Villaruz, Dan P. Zandberg, Pablo Sanchez, MD, and Ibrahim Sultan, MD.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Parotid Gland Cancer
Global LeaderStage IV
Stage I
Stage II
Top PIs
Liza C. VillaruzUniversity of Pittsburgh Cancer Institute (UPCI)6 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
40 reported clinical trials
59 drugs studied
Dan P. ZandbergUniversity of Pittsburgh Cancer Institute (UPCI)4 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Squamous Cell Carcinoma
20 reported clinical trials
36 drugs studied
Pablo Sanchez, MDResearch Institute at Nationwide Children's Hospital6 years of reported clinical research
Studies Neonatal Diseases
Studies Low Birth Weight
14 reported clinical trials
22 drugs studied
Ibrahim Sultan, MDUniversity of Pittsburgh Medical Center3 years of reported clinical research
Studies Congenital Aortic Stenosis
Studies Aortic Stenosis
11 reported clinical trials
19 drugs studied
Clinical Trials running at UPMC-Presbyterian Hospital
Lung Cancer
Stroke
Parotid Gland Cancer
Laryngeal Cancer
Heart Failure
Brain Metastasis
Skin Cancer
Cancer
Colon Cancer
Sleep Apnea
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Stereotactic Radiosurgery vs Whole-Brain Radiotherapy
for Brain Metastasis from Lung Cancer
This phase III trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the treatment of small cell lung cancer that has spread to the brain. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue. Whole brain radiation therapy delivers a low dose of radiation to the entire brain including the normal brain tissue. Hippocampal avoidance during whole-brain radiation therapy (HA-WBRT) decreases the amount of radiation that is delivered to the hippocampus which is a brain structure that is important for memory. The drug, memantine, is also often given with whole brain radiotherapy because it may decrease the risk of side effects related to thinking and memory. Stereotactic radiosurgery may decrease side effects related to memory and thinking compared to standard of care HA-WBRT plus memantine.
Recruiting2 awards Phase 315 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UPMC-Presbyterian Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.